Pfizer y su socio BioNTech dicen que dos de sus vacunas experimentales contra el coronavirus recibieron la designación de “vía rápida” de la FDA

Pfizer Inc and partner BioNTech SE said two of their experimental coronavirus vaccines received ‘fast track’ designation from the U.S. Food and Drug Administration, speeding up the regulatory review process.

Fuente: Youtube